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 Introduction
Australian bat lyssavirus (ABLV) belongs to the genus
ssavirus of the family Rhabdoviridae within the order
ononegavirales (ICTV, http://www.ictvonline.org/virus-
Taxonomy.asp). The genus is represented by rabies virus
(RABV, genotype 1) and comprises Lagos bat virus (LBV,
genotype 2), Mokola virus (MOKV, genotype 3), Duvenhage
bat virus (DUVV, genotype 4), European bat lyssavirus 1
and 2 (EBLV-1 and 2, genotypes 5 and 6, respectively),
Australian bat lyssavirus (ABLV, genotype 7), Irkut bat
virus (IRKV, genotype 8), Aravan bat virus (genotype 9),
Khujand bat virus (KHUV, genotype 10), West Caucasian
bat virus (WCBV, genotype 11) and Shimoni bat virus
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A B S T R A C T
In May 2013, the ﬁrst cases of Australian bat lyssavirus infections in domestic animals
were identiﬁed in Australia. Two horses (ﬁlly-H1 and gelding-H2) were infected with the
Yellow-bellied sheathtail bat (YBST) variant of Australian bat lyssavirus (ABLV). The horses
presented with neurological signs, pyrexia and progressing ataxia. Intra-cytoplasmic
inclusion bodies (Negri bodies) were detected in some Purkinje neurons in haematoxylin
and eosin (H&E) stained sections from the brain of one of the two infected horses (H2) by
histological examination. A morphological diagnosis of sub-acute moderate non-
suppurative, predominantly angiocentric, meningo-encephalomyelitis of viral aetiology
was made. The presumptive diagnosis of ABLV infection was conﬁrmed by the positive
testing of the affected brain tissue from (H2) in a range of laboratory tests including
ﬂuorescent antibody test (FAT) and real-time PCR targeting the nucleocapsid (N) gene.
Retrospective testing of the oral swab from (H1) in the real-time PCR also returned a
positive result. The FAT and immunohistochemistry (IHC) revealed an abundance of ABLV
antigen throughout the examined brain sections. ABLV was isolated from the brain (H2)
and oral swab/saliva (H1) in the neuroblastoma cell line (MNA). Alignment of the genome
sequence revealed a 97.7% identity with the YBST ABLV strain.
Crown Copyright  2014 Published by Elsevier B.V. All rights reserved.
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BLV is related to other bat lyssaviruses but it is most
losely related to classical rabies virus (Gould et al., 1998).
ence, the cross-protection against ABLV infection pro-
ided by currently used rabies vaccines (Fooks, 2004).
BLV causes similar neurological symptoms to rabies in
umans (Allworth et al., 1996; Hanna et al., 2000;
amaratunga et al., 1998). ABLV was ﬁrst described in a
lack ﬂying fox (Pteropus alecto) in 1996 by Fraser et al.
996); however, retrospective testing of archival brain
ssues indicated that there was an earlier case in 1995.
his variant was also detected in the grey-headed ﬂying
x (Pteropus poliocephalus), the spectacled ﬂying fox
teropus conspicillatus) and the little red ﬂying fox
teropus scapulatus). Another variant of ABLV was later
olated from a species of insectivorous microbat, the
ellow-bellied sheath tail bat (YBST) (Saccolaimus ﬂavi-
entris) (Gould et al., 2002; Hooper et al., 1997). Therefore,
ere are two distinct variants of ABLV affecting frugivo-
ous and insectivorous bats, respectively.
Spill-over of bat lyssavirus infection have been
reviously reported and bat lyssaviruses are known to
fect humans, domestic animals and wildlife (Fooks
t al., 2003; Mu¨ller et al., 2004; Ronsholt, 2002). In 2009,
acheux et al. (2009) suspected bat-to-cat transmissions
f EBLV on two occasions, when EBLV-1 was recovered
om 2 domestic cats in France. Similarly, (Mu¨ller et al.,
004) reported a lyssavirus infection in a stone marten in
ermany. Furthermore, Brookes et al. (2007) reproduced
he disease experimentally in sheep, and Cliquet et al.
2009) compared the susceptibility of foxes to EBLV type
 and 2 using intracranial and peripheral (intramuscular)
oculation methods and demonstrated a low spill-over
hance of EBLV from bat to fox with EBLV-1 having a
reater probability to do so than EBLV-2. In a series of
xperiments, Vos et al. (2004a,b) infected ferrets and
xes with EBLV-1, however they showed that these
pecies were unlikely to transmit the virus to another
ost. In the United States of America, it has been shown
hat spill-over events have occurred and have resulted in
he permanent adaptation of bat lyssavirus variants in
accoons, skunks, foxes, coyotes, mongooses, groundhogs
nd bobcats (Krebs et al., 2000). Similar events have been
eported in Africa, particularly in Southern Africa, with
daptation of bat lyssavirus variants in mongooses,
ckals and bat-eared foxes (Bengis et al., 2004). In South
merica, there have been reports of transmission of bat
ssavirus from wildlife, especially vampire bats (Favor-
tto et al., 2013).
According to the recommendations of the World Health
rganization (WHO) and the World Organization for
nimal Health (OIE), the ﬂuorescent antibody test (FAT)
 the method of choice for the identiﬁcation of lyssavirus
 the brain stem (thalamus, pons and medulla). Although
AT is the gold standard assay for the identiﬁcation of
ssavirus in tissues, in recent years advances in molecular
iagnostics have seen wide use of conventional and real-
me RT-PCR for the diagnosis of lyssavirus infections
anyard et al., 2009; Black et al., 2002; Echevarrı´a et al.,
001; Foord et al., 2006; Smith et al., 2002; Va´zquez-
oro´n et al., 2006; Wakeley et al., 2005).
Until recently, the only cases of lyssavirus infection
recorded in Australia were in bats and humans. However,
in May 2013 two horses were diagnosed with ABLV and are
the ﬁrst conﬁrmed Australian ﬁeld infections. We describe
these 2 cases and discuss the relevance of these ﬁndings to
the management of ABLV infections in domestic animals in
Australia.
2. Materials and methods
2.1. Clinical presentation
2.1.1. Horse 1 (H1)
On May 5, 2013, a female yearling presented with
pyrexia, subtle neurological signs and progressive ataxia.
The attending equine practitioner submitted blood (EDTA),
nasal, rectal and oral swabs to the Biosecurity Sciences
Laboratory (BSL) for Hendra virus (HeV) testing. However,
the horse deteriorated and it was euthanized, and no
further samples were taken. Samples were tested the same
day and were negative. As a differential diagnosis, the
submitting veterinarian requested tests for ﬂavivirus
infection which were negative.
2.1.2. Horse 2 (H2)
Within four days of H1 becoming symptomatic, a male
yearling from the same paddock presented with similar
neurological signs. Samples were submitted for HeV,
equine herpesvirus type 1 and ﬂavivirus testing; all
samples were negative. H2 deteriorated over the following
3 days and was euthanized. On advice of the duty
pathologist, the veterinarian performed a necropsy and
submitted samples preserved in 10% neutral buffered
formalin and unpreserved samples from the central
nervous system to BSL for testing. The preserved samples
included small pieces of cerebral cortex, cerebellum, brain
stem and spinal cord. The rest of the brain and cerebro-
spinal ﬂuid were unpreserved. The unpreserved brain was
stored at 20 8C after being sub-sampled for further
testing soon after its delivery to the laboratory; therefore,
further histological examination was not possible.
2.2. Histopathology
Central nervous system specimens including small
portions of cerebral cortex, cerebellum, brain stem and
cervical spinal cord from horse 2 were ﬁxed in 10% neutral
buffered formalin, and embedded in parafﬁn. Sections
were cut at 4 mm thickness using a microtome (Microm
HM325, Thermo), stained with haematoxylin and eosin
(H&E) and examined.
2.3. Immunohistochemistry (IHC)
Additional sections for IHC were cut onto positively
charged slides and placed in a 40 8C incubator to dry
overnight. Following 10 min incubation in a 60 8C oven, the
slides were dewaxed and brought to water.
Antigen retrieval was induced through heat treatment
by placing the sections in EnVision Flex Target Retrieval
Solution, High pH (Dako, Denmark) for 30 min at 97 8C
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ash in EnVision Flex Wash Buffer, the slides were placed
to the Dako Autostainer where endogenous peroxidases
ere quenched with 3% hydrogen peroxide for 10 min.
des were then rinsed with buffer and the primary
tibody was applied for 60 min. Sections were then rinsed
ith buffer and a secondary antibody, EnVision Flex/HRP
ako, Denmark), was applied for 20 min, followed by a
rther rinse of buffer and application of AEC+ High
nsitivity Substrate Chromogen (Dako, Denmark) for
 min. Following a distilled water rinse, sections were
moved from the Autostainer, counterstained with Lillie-
ayer’s haematoxylin and mounted using Dako Fara-
ount Aqueous Mounting Medium (Dako, Denmark). Five
imary antibodies were used, each on separate slides: a
onoclonal antibody 5DF12 (supplied by Alex Wandeler,
rmerly of the Centre of Expertise for Rabies, Canadian
od Inspection Agency, Ottawa), and four rabbit antisera
ised against the nucleoprotein of rabies virus (CSIRO –
stralian Animal Health Laboratory, Geelong, Australia).
. Cell culture and virus isolation
The mouse neuroblastoma cell line, MNA, was main-
ined in growth medium (Opti-MEM with 3% FCS, 100 U/
L of penicillin, 100 mg/mL of streptomycin and 0.25 mg/
L of Fungizone1) at 37 8C under 5% CO2. To obtain a viral
late, a suspension of infected horse brain was ground
en ﬁltered (0.22 mm) and used to infect a monolayer of
NA cells. After initial infection, four weekly serial
ssages were performed, and successful infection was
nﬁrmed by immuno-ﬂuorescence antibody test on ﬁxed
lls.
. Direct immunoﬂuorescent antibody assay (FAT)
FAT uses a monoclonal antibody conjugated with
orescein isothiocyanate (FITC, Fujirebio Diagnostics,
eden). Brain tissue was cross-sectioned and impression
ears were done on a microscope slide. The slides were
ed in acetone for 1 h at room temperature and allowed
 air dry. Two drops of FITC-conjugated monoclonal
tibody were added to the smear and incubated in a
mid chamber at room temperature for 30 min. Unbound
tibody was washed off with phosphate buffered saline
BS) and the slides were mounted with cover slips using
ycerol mounting medium (90% glycerol in PBS). Slides
ere examined using a ﬂuorescent microscope (Leitz
borlux II). Negative and positive controls were included
 the assay.
. Multiplex real-time PCR
RNA was extracted from brain and oral swabs using the
-1 robot (Qiagen, Australia). RNA was tested using a
ultiplex real-time PCR which combines two ﬂuorogenic
says targeting the nucleocapsid gene of both variants of
LV as described by Smith et al. (2002). Five microlitres of
A template was added to 20 ml of SuperScriptTM
atinum III One-step RT PCR mastermix. The PCR was
n using fast cycling parameters [50 8C for 5 min; 95 8C for
2 min]1[95 8C for 3 s; 60 8C for 30 s]40 Fluorescence signal
was acquired on the FAM channel (for frugivorous ABLV
variant) and VIC (for YBST ABLV variant) channel. For
quality assurance purposes, negative and positive controls
were included in the run.
2.7. Sequence-independent ampliﬁcation
Cell debris was removed from the viral tissue culture
supernatant by centrifugation (3000 rpm; 10 min; room
temperature) followed by ﬁltration (0.22 mm). Contami-
nating nucleic acids were removed by enzymatic digestion
with RQ1 DNase (1 U/ml) and RNase ONE (2 U/ml) at 37 8C
for 30 min. Ultra-centrifugation was used to sediment
virus particles (100,000  g; SwTi55 rotor; 2 h; 4 8C) which
were resuspended in sterile PBS on ice overnight. A
QIAamp Viral RNA extraction kit (Qiagen) was used for
nucleic acid extraction as per manufacturer’s recommen-
dations; however, carrier RNA was omitted from the AVL
buffer. Reverse transcription was performed using the
extracted RNA (5 mL) as template and random hexamers
attached to an arbitrary sequence (C-6N 50-GAGAAACC-
CACCACCAGANNNNNN-30). Second strand DNA synthesis
was performed using the SuperScriptTM III One-Step RT-
PCR System with Platinum1 Taq High Fidelity mix (Life
Technologies) with the following cycling conditions [25 8C
for 5 min; 37 8C for 30 min; 95 8C for 2 min]1[95 8C, 30 s;
25 8C, 30 s; 72 8C, 2 min]5. The cDNA (2 mL) was used as a
template for ampliﬁcation in a mix containing a primer
with the arbitrary sequence shown above (Primer C 50-
GAGAAACCCACCACCAGA-30) and AmpliTaq Gold thermo-
stable DNA polymerase. The cycling parameters were as
follows: [95 8C, 12 min]1[95 8C, 30 s; 59 8C, 30 s; 72 8C,
2 min]50[72 8C, 7 min]1[15 8C]hold.
2.8. Library preparation
DNA samples were sheared to approximately
230–250 bp fragments using an S2 sonicator (Covaris
Inc., MA, USA). Sequencing libraries were prepared using
an NEBNext Ultra library kit (New England Biosciences)
with local modiﬁcations and quantiﬁed using a High
Sensitivity DNA chip on a Bioanalyzer 2100 (Agilent
Technologies, CA, USA).
2.9. Template preparation and sequencing
Two barcoded samples were pooled in equimolar ratios
to a total concentration of 12 pM in low TE buffer (10 mM
Tris–HCl + 0.1 mM EDTA). Template preparation and en-
richment was performed using an Ion OneTouch2 Tem-
plate 200 Kit (Life Technologies, NY, USA) on a OneTouch 2
and OneTouch ES (Life Technologies, NY, USA). Sequencing
was performed using an Ion PGM 200 Sequencing Kit on a
‘‘316’’ sequencing chips for a total of 500 nucleotide ﬂows,
yielding average read lengths of 220–230 bp. Primary
analysis (i.e. base-calling and barcode de-convolution) was
performed using Torrent Suite 3.6.2. Initially, reads were
trimmed of adaptor sequences and ﬁltered to remove
polyclonal and low quality reads. They were then trimmed
to remove poor quality bases at the 30 end of long reads.
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as imported into Geneious Pro software v5.6 (Kearse
t al., 2012). The reads were then re-trimmed to remove 30
ucleotides from the 50 and 30 ends of each read. A virus
onsensus sequence was assembled from the trimmed
ata using Geneious Pro software v5.6 and using the ABLV
BST strain (NCBI accession number NC_003243.1) as a
eference sequence, with the assembly sensitivity set at
e highest level.
.10. Bioinformatics
For nucleotide sequence identity scores, the Geneious
lignment feature was used (cost matrix 65% similarity;
ap open penalty, 12; gap extension penalty, 3). Multiple
ucleotide sequence alignment was performed using the
AFFT plugin (scoring matrix 200PAM/k = 2; gap open
enalty, 1.53; offset value, 0.123). A mid-point rooted
hylogenetic tree was generated with the multiple
lignment output by the neighbour joining method of
EGA5 (Tamura et al., 2011) using the estimated gamma
arameter (Jukes-Cantor model and complete gap dele-
on) with 1000 bootstrap replicates.
. Results
.1. Histopathological ﬁndings
Tissues were well preserved but some distortion,
robably due to the sampling process, was evident in all
f the examined sections. The histopathological ﬁndings
onsistent with a subacute non-suppurative meningo-
ncephalomyelitis of viral aetiology (Fig. 1A) were present
 all of the examined sections. The angiocentric cellular
eaction mainly consisted of mononuclear cells including
mphocytes, macrophages, and reactive endothelial and
lial cells. In addition, variable numbers of neutrophils
ere also present in some of the vasocentric foci. The
erivascular cufﬁng and focal non-suppurative meningitis
ere more prominent in the cerebellum. Occasional small
cal gliosis was also detected in brain stem. The disease
rocess affected both white and grey matter.
Neuronal degeneration and necrosis (Fig. 1B and C)
ere more noticeable in the spinal cord and brain stem.
espite considerable tissue distortion some neuronal
hanges such as cytoplasmic hypereosinophilia, central
hromatolysis, nuclear karyorrhexis, karyopyknosis or
eir absence, were suggestive of degeneration and
ecrosis (Fig. 1B and C). Patchy white matter vacuolation
as noticed in spinal cord section. Non-speciﬁc changes
cluding oedema and random perivascular haemorrhages
ere also observed.
Eosinophilic intra-cytoplasmic viral inclusions (Negri
odies) in Purkinje neurones (Fig. 1B) and scattered
lsewhere (Fig. 1C) were supportive of virus infection.
ligo-inclusions were often relatively large spheroids
hich were intensely eosinophilic and had a tendency
 occur peripherally close to the cell membrane (Fig. 1B).
oly-inclusions were numerous, small, and irregularly
haped with varying staining intensity and often had a
entro-positioning afﬁnity (Fig. 1C).
The immuno-histochemistry (IHC) slides showed
widespread presence of viral nucleoprotein antigen in all
of the examined sections (Fig. 1D–F). The particulate
antigen staining of variable size was found within the
cytoplasm of the nerve cell bodies and in the neuropil. Each
of the ﬁve primary antibodies stained in a similar manner.
3.2. FAT and real-time PCR
The brain was reactive with antibodies to lyssavirus
using the immunoﬂuorescent antibody test (data not
shown). RNA extracts from oral swabs (H1 and 2) and brain
(H2) were also positive in the YBST strain-speciﬁc real-
time RT-PCR (Smith et al., 2002) but were negative in the
pteropid strain speciﬁc real-time RT-PCR. Retrospective
testing by real-time PCR of a retained oral swab from the
H1 was also consistent with YBST strain lyssavirus
infection. This conﬁrmed the diagnosis of lyssavirus
infection by histopathology.
3.3. Analysis of ABLV horse isolate
An isolate was obtained from the brain of the infected
horse using mouse neuroblastoma cells (MNA). Sequenc-
ing was performed on the isolate (GenBank accession
number: KJ685548) which included the entire predicted
open reading frames (ORFs). A global nucleotide sequence
alignment with the two currently available ABLV genome
sequences (Fig. 2A) revealed that the isolate was most
similar to a strain from the insectivorous microbat
Saccolaimus ﬂaviventris (Gould et al., 2002) with which it
had a 97.7% sequence identity, compared to only 82.6%
shared identity with the human isolate of ﬂying fox origin.
4. Discussion
Under normal circumstances, in cases of horses with
neurological symptoms, samples are submitted for Hendra
virus (HeV) infection exclusion, and ABLV testing should be
considered as a differential diagnosis; however, this is not
always possible as veterinarians are reluctant to undertake
autopsies of such horses. Alternative sampling methods
should be considered, such as the occipital foramen
method (Barrat and Blancou, 1988) or the retro-orbital
method (Montano Hirose et al., 1991). If Hendra testing by
real-time PCR returns negative results, samples are tested
additionally for ﬂaviviruses and also equine herpesvirus
type 1 which are known to cause neurological disease in
horses. With regard to the latter, there were no reports of
infection in Queensland; however, there have been two
cases elsewhere in Australia (Carroll and Westbury, 1985;
Studdert et al., 2003).
The fact that oral swabs from both horses were positive
is signiﬁcant because the use of oral swabs from horses
with neurological signs may improve the conﬁdence in the
diagnosis. It is a well-established fact that rabies virus is
transmitted through saliva of a rabid animal (Vaughn et al.,
1965). Echevarrı´a et al. (2001) have successfully used
oropharyngeal swabs for epidemiological studies of EBLV
in a serotine bat colony. However, it would be risky to base
the diagnosis on oropharyngeal swab/saliva testing alone
as
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emachudha et al., 2002; Leung et al., 2007). Therefore,
gative PCR results from saliva samples should be
terpreted with caution.
In this case a multidisciplinary diagnostic approach
abled a correct diagnosis of ABLV infection. The
eliminary histopathological ﬁndings were essential for
e diagnostic outcome. Most of the detected histological
atures in this case are similar to those described in ABLV
fected bat brains (Hooper et al., 1999) and recorded
man ABLV infection (Samaratunga et al., 1998). The
agnosis of ABLV infection in this case clearly highlights
the importance of basic ﬁrst principles in signiﬁcant
veterinary diagnoses. The initial observation of Negri
bodies in the cerebellum suggested a lyssavirus infection.
This was conﬁrmed using the FAT, which is the accepted
universal assay for all lyssaviruses. Further investigation
including virus isolation, sequencing of the entire ORF of
the isolate and real-time RT-PCR enabled the identiﬁcation
of the pathogen as the YBST bat strain of ABLV. Other
workers have reported difﬁculties detecting bat lyssavirus
in the brain of other species including cats (Dacheux et al.,
2009), sheep (Tjørnehøj et al., 2006) and stone marten
(Mu¨ller et al., 2004). Dacheux et al. (2009) hypothesised
. 1. Histopathological and immunohistochemical ﬁndings for Horse 2. (A) Cerebrum: small vessel with thin perivascular cuff (predominantly
phocytic), indicative of non-suppurative encephalitis (haematoxylin and eosin, H&E). (B) Cerebellum: neuronal intra-cytoplasmic eosinophilic viral
lusions (broken arrows) within large Purkinje cell body. Note the indicators of cell degeneration: poorly discernable nucleus of Purkinje cell (solid black
ow). (C) Cervical spinal cord, showing large neuron with disintegrating nucleus and multiple small eosinophilic intracytoplasmic inclusions (broken
ows). Note the faint-staining degenerate nucleus (solid arrow) (H&E). (D) Cervical spinal cord demonstrating dense and widespread viral antigen in grey
tter (immunohistochemistry (IHC) for Lyssavirus nucleoprotein – brownish red colour). (E) Cerebellum, showing viral antigen distributed throughout
 layers of the grey matter and which is particularly dense in the Purkinje cell bodies (IHC). (F) Cerebral cortex, showing variable-sized particulate viral
tigen bodies in the cytoplasm of neurons and in the neuropil. Scale bars: 50 mm for A, B, C and F; 100 mm for D and E. (For interpretation of the references
color in text, the reader is referred to the web version of this article.)
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uggested the use of variety of techniques to diagnose
BLV infection. Mu¨ller et al. (2004) reported a lack of
ensitivity of FAT in the stone marten case, whereas the
st was repeatedly negative and a deﬁnite diagnosis was
nly achieved by mouse inoculation and RT-PCR positive
esults. This is signiﬁcant as FAT is considered the gold
tandard for lyssavirus detection in brain tissues. Contrary
 what was previously reported for classical rabies in
omestic species, Bingham and van der Merwe (2002)
howed that the hippocampus and the cerebellum can
ield negative FAT results in 4–5% of the cases, while
ifferent parts of the cerebrum can yield up to 11% of FAT
egatives on known positive brains. They recommended
e testing of multiple sub-samples of the brain, and in
articular the thalamus, where viral antigen was most
bundant.
The histo-pathological ﬁndings were consistent with a
on-suppurative meningo-encephalitis of viral aetiology,
hich is characteristic of a lyssavirus infection. The
resence of intracytoplasmic inclusions was indicative of
pical Negri bodies, a pathogenomic feature of lyssavirus
fection. It is interesting to note that according to other
ublished works (Dacheux et al., 2009; Mu¨ller et al., 2004;
jørnehøj et al., 2006) this seems to be a rare event as in
ost cases when domestic animals and foxes are infected
ith bat lyssaviruses, Negri bodies are rarely observed. The
uthors hypothesised that it might be due to a low viral
ad. It is to be noted in this particular case, the real-time
PCR (Ct of 24) and strong FAT staining suggested a high
viral load.
Sequencing of the entire ORF of the isolate enabled its
identiﬁcation. Pairwise alignment of the genome sequence
conﬁrmed the isolates close association with the YBST bat
strain (97.7% identity). The genome sequence of an isolate
that was obtained from a fatal human case in 1998
(Warrilow et al., 2002), who was infected by an unidenti-
ﬁed species of ﬂying fox, had only 82.6% nucleotide
identity with the horse isolate. A phylogenetic analysis of
the genome sequence conﬁrmed the isolates close
association with the YBST bat strain (Fig. 2B). Hence, the
sequence analysis indicated that the horse was most likely
infected by an YBST microbat.
The isolate had a putative transcription termination
signal (TGGA6C) located between the phosphoprotein and
matrix ORFs (Table 1) which differed from the consensus
signal sequence (TGA7C) for lyssaviruses (Bourhy et al.,
1990). Interestingly, a change in that signal sequence also
occurred in an isolate from an insectivorous bat (Gould
et al., 2002). In addition, a change was also reported
previously in that signal for the isolate from the human
ABLV infection (Warrilow et al., 2002). In that case, as the
sequence change was only detectable in the isolate and
not the original brain material, it was attributed to a
possible cell culture adaptation. Hence for the horse
isolate, this transcription termination signal change may
also indicate an adaptation of the virus to cell culture.
In addition, the horse isolate was different from the
ig. 2. Analysis of the genome of the ABLVhorse isolate. (A) The genome of the ABLVhorse isolate was aligned with the ABLVYBST strain. The predicted open
ading frames (ORFs) are shown in yellow and gaps are indicated by spaces. (B) A phylogenetic tree with the ABLVhorse isolate in relation to the other
ssavirus species including: ABLVYBST (NC_003243.1), ABLVhuman (AF418014.1), rabies (M13215.1), Aravan virus (EF614259.1), Khujand virus
F614261.1), European bat lyssavirus 2 (EU293114.1), Duvenhage virus (EU293119.1), Irkut virus (EF614260.1), European bat lyssavirus 1 (EU293112.1),
okola virus (NC_006429.1), Lagos bat virus (EU293108.1), and West Caucasian bat virus (EF614258.1) is shown. A complete genome sequence for the
teropid strain of ABLV was not available. The tree was constructed from an alignment of the nucleotide sequences covering the complete coding regions.
ootstrap values are shown as a percentage of 1000 replicates. (For interpretation of the references to color in text, the reader is referred to the web version
f this article.)
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e two carboxy-terminal amino acids of the glycoprotein
ig. 3). A similar observation was made previously when
mparing the same region of the human isolate with the
ing fox strain (Warrilow et al., 2002). As the changes
ried depending on the host from which it was isolated,
e sequence variability may reﬂect species-speciﬁc
aptation.
Although Australia is considered free of rabies (AHA,
11), there have been three human cases of ABLV
fection of which two were due to the pteropid strain
 ABLV and one was due to the insectivorous strain. Due to
e low frequency of infections of the ABLV in general, and
e YBST bat strain in particular, it was surprising that two
fections of horses should have occurred simultaneously
 the same property. Unlike the larger fruit bats that often
teract with dogs and cats because they are more
iquitous and often found feeding in backyards, insectiv-
ous bats are more furtive and feed mainly by hawking
cKenzie, 2008). As a result, they are less likely to interact
ith companion and domestic animals. It is not known
w the two horses were simultaneously infected. One
ssibility is that the horses may have come in contact
ith one or more lyssavirus-infected YBST bats and were
her bitten or scratched by the latter, perhaps in the same
cident. Subsequent investigations on the property failed
 establish a direct link with YBST bats. It is also worth
ting that this event could have happened anytime
tween 2 weeks and 2 years post-infection. In a series of
dies (Constantine, 1966; Constantine et al., 1968;
cColl et al., 2007; Murphy et al., 1980), it was shown
at the majority of domestic animals experimentally
fected, initially recovered and developed antibodies, but
en some succumbed to rabies after 2 years. McColl et al.
007) were unable to reproduce rabies in cats and dogs
perimentally during a 3-month observation. All animals
der investigation recovered and seroconverted within 2
eeks post infection. They concluded that there may be
me difference in pathogenicity between terrestrial-
imal-derived lyssaviruses and bat-derived lyssaviruses.
wever, the present report conﬁrms that bat-derived
lyssaviruses infections can be as fatal as terrestrial animal-
derived lyssavirus infection.
Currently, Australian legislation does not allow the
vaccination of domestic animals against rabies unless they
are imported or exported. This policy may need to be
re-considered as it is now clear that ABLV infection
presents a risk to domestic animals, their human owners
and veterinary workers.
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